tiprankstipranks
Kintara Expands Clinical Study with Pembrolizumab
PremiumCompany AnnouncementsKintara Expands Clinical Study with Pembrolizumab
22d ago
Kintara Therapeutics expands inclusion criteria in REM-001 study
PremiumThe Fly
Kintara Therapeutics expands inclusion criteria in REM-001 study
22d ago
Kintara Therapeutics Halts ATM Offerings and Equity Facility Usage
PremiumCompany Announcements
Kintara Therapeutics Halts ATM Offerings and Equity Facility Usage
2M ago
Kintara Therapeutics Announces Review of Strategic Alternatives
PremiumPress ReleasesKintara Therapeutics Announces Review of Strategic Alternatives
4M ago
Kintara Therapeutics initiates review of strategic alternatives
PremiumThe Fly
Kintara Therapeutics initiates review of strategic alternatives
4M ago
Kintara Therapeutics granted extension by Nasdaq to regain compliance
PremiumThe Fly
Kintara Therapeutics granted extension by Nasdaq to regain compliance
5M ago
Kintara Therapeutics presents results from Phase 2 study of VAL-083
PremiumThe FlyKintara Therapeutics presents results from Phase 2 study of VAL-083
7M ago
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update
PremiumPress Releases
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update
7M ago
EmergingGrowth.com to host a virtual conference
PremiumThe Fly
EmergingGrowth.com to host a virtual conference
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100